Undă verde: Statul finanțează ROMATSA prin Exim Banca Românească până la încheierea litigiului cu Pfizer

The Romanian Parliament approved a temporary financing mechanism for ROMATSA through EximBank to ensure its operations amid ongoing disputes with Pfizer. This measure aims to address liquidity needs while negotiations continue. ROMATSA's management clarified that they are not seeking state subsidies but a recoverable bridge financing until revenue streams are restored. The financial strain arises from Pfizer's enforcement actions following a court ruling, which has led to the freezing of funds collected by EUROCONTROL, significantly impacting ROMATSA's income. Authorities assure that air traffic and safety remain unaffected, but prolonged revenue blockage could escalate liquidity issues.